Navigation Links
National Family Partnership Designates October 27th 'Lock Your Meds' Day
Date:10/15/2008

First Monday of Red Ribbon Week Will Educate Parents about Prescription Drug Abuse

MIAMI, Oct. 15 /PRNewswire/ -- The National Family Partnership (NFP) has designated Monday, October 27th as the first "Lock Your Meds" Day, kicking off the group's 23rd annual Red Ribbon Week from October 27-31, to raise awareness and provide parents with action steps to prevent children's prescription drug abuse.

Statistics show that over 3 million teens in the United States abuse prescription drugs each year. More startling, 70 percent of children who abuse prescription drugs admit to getting them from friends and family, often taken from the home medicine cabinet without that person's knowledge.

For this reason, the National Family Partnership, with support from Alpharma Pharmaceuticals Inc., is dedicating the first Monday of its Red Ribbon Week, the oldest and largest drug abuse prevention program in the United States, towards stemming the growing problem of prescription drug abuse, particularly among teens and children.

"The National Family Partnership has designated 'Lock Your Meds' Day because we realize the impact that prescription drug abuse is having on families," said Peggy Sapp, executive director of National Family Partnership. "Parents hold the key to their children's drug-free future, and it is our hope that day not only brings more awareness to the problem but also enables greater family involvement to help to curb this dangerous trend."

The first "Lock Your Meds" Day urges parents to take the following steps to prevent teen prescription drug abuse:

-- Lock your prescription medication and prevent abuse or misuse by

securing the medication in your home.

-- Take inventory of your current medications and periodically check that

nothing is missing.

-- Educate yourself and your children about the most commonly abused types

of prescription medications and communicate the dangers to your child

regularly.

-- Set clear rules and monitor behavior by expressing your disapproval of

using prescription drugs without a prescription.

-- Properly dispose of old and unused medications.

To help parents take these steps and combat the problem of prescription drug abuse in their homes, the campaign web site (http://www.nfp.org/lockyourmeds) includes easy-to-use resources such as a home medicine inventory card, an online pledge and downloadable guidelines on how to properly dispose of prescription medicine.

Each year, the Red Ribbon Campaign reaches millions of young people during Red Ribbon Week who are asked to wear a symbolic red ribbon to show their personal commitment to a drug-free lifestyle. The mission of the Red Ribbon Campaign is to present a unified and visible commitment towards the creation of a drug-free America.

The Red Ribbon Campaign was launched when drug traffickers in Mexico City murdered DEA agent Kiki Camarena in 1985, thus beginning the continuing tradition of displaying Red Ribbons as a symbol of intolerance towards the use of drugs. The theme for this year's campaign is "Ask Me, See Me, Be Me, I'm Drug Free."

For more information on teen prescription drug abuse or to download "LOCK YOUR MEDS" materials, please visit http://www.nfp.org/lockyourmeds or call 305-856-4886 or toll-free at 800-705-8997.

About the National Family Partnership

The National Family Partnership (NFP), formerly known as the National Federation of Parents for Drug Free Youth, was created in 1980 by parents across America in response to the rising level of youth drug use. The mission of the National Family Partnership is nurturing parents to help children reach their full potential. The National Family Partnership works to accomplish its mission through parent training, parent networking and sponsoring the National Red Ribbon Campaign. The Partnership also assists in forming parent groups in all 50 States, provides education to parents about the health risks of drug use, distributes similar materials to members of Congress and supports alternative social activities for youth.

About Alpharma

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 80 countries. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with its KADIAN(R) (morphine sulfate extended-release) Capsules, and the FLECTOR(R) Patch (diclofenac epolamine topical patch) 1.3%. Alpharma is also internationally recognized as a leading provider of pharmaceutical products for poultry and livestock. For more information, please visit http://www.alpharma.com.

For more information contact:

Punnie Donohue, Weber Shandwick

(212) 445-8163

pdonohue@webershandwick.com


'/>"/>
SOURCE The National Family Partnership (NFP)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Midlothian Resident Katherine McCary Appointed by President Bush to National Council on Disability
2. National RN Union Launches Multi-State Drive for Healthcare Voters With Road Show in Nevada, October 13 Through 17
3. The Latino Commission on AIDS Call on Presidential Candidates to Honor National Latino AIDS Awareness Day on October 15
4. Action Donation Services Welcomes Joanne Olson as New National Client Charity Representative
5. Cancer screening rates among older Medicaid patients fall short of national objectives
6. Carnegie Mellon International Autism Symposium to Feature Groundbreaking Research, Oct. 17-18
7. Supporting Susan G. Komen for the Cure(R) During National Breast Cancer Awareness Month
8. Texas Back Institute Announces Nine for Your Spine for National Spine Health Day - October 16
9. National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography
10. National Psoriasis Foundation Releases 2008 Study Results
11. Children's National Experts Presenting at American Academy of Pediatrics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... Boulder, CO (PRWEB) , ... April 25, 2017 ... ... Law and Liberty attempts to compare student test score performance for the 2015-16 ... one of the state’s voucher programs. Though it highlights important patterns in student ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America (BPC), ... reputable physician in their area, announces the launch of a new and proprietary customer ... are looking for reputable physicians to help them with back or neck pain and ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... Calif. , April 19, 2017  SARES•REGIS ... buildings it is developing at Conejo Spectrum Business ... , to Atara Biotherapeutics, Inc. , a ... severe and life-threatening diseases that have been underserved ... allogeneic T-cell therapies for cancer, autoimmune and infectious ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: